![Klaudia Smolana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Klaudia Smolana is currently the Chairman and Chief Executive Officer at Intelliseq SA since 2015.
Cargos activos de Klaudia Smolana
Empresas | Cargo | Inicio |
---|---|---|
Intelliseq SA
![]() Intelliseq SA Internet Software/ServicesTechnology Services Intelliseq SA is a Polish genome informatics company that specializes in creating algorithms and bioinformatic tools to interpret the human DNA sequence. The company was founded in 2014 by Marcin Piechota, Michal Korostynski, Slawomir Golda, and is currently based in Kraków, Poland. Intelliseq's interdisciplinary team of experts in genomics, molecular biology, bioinformatics, and software development aims to support whole-genome scientific research and the genetic diagnosis process. The company delivers an automatic and scalable SaaS platform for genome data analysis with no upfront cost. The company's goal is to fill a void in translating genetics knowledge into products and make DNA analysis simple. | Director Ejecutivo | 01/02/2022 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Intelliseq SA
![]() Intelliseq SA Internet Software/ServicesTechnology Services Intelliseq SA is a Polish genome informatics company that specializes in creating algorithms and bioinformatic tools to interpret the human DNA sequence. The company was founded in 2014 by Marcin Piechota, Michal Korostynski, Slawomir Golda, and is currently based in Kraków, Poland. Intelliseq's interdisciplinary team of experts in genomics, molecular biology, bioinformatics, and software development aims to support whole-genome scientific research and the genetic diagnosis process. The company delivers an automatic and scalable SaaS platform for genome data analysis with no upfront cost. The company's goal is to fill a void in translating genetics knowledge into products and make DNA analysis simple. | Technology Services |
- Bolsa de valores
- Insiders
- Klaudia Smolana